
SAN FRANCISCO - The disease modifying antirheumatic drug (DMARD) leflunomide (Arava), approved for use in rheumatoid arthritis, may also be an effective therapy for recalcitrant psoriatic arthritis and psoriasis, according to two new studies.

SAN FRANCISCO - The disease modifying antirheumatic drug (DMARD) leflunomide (Arava), approved for use in rheumatoid arthritis, may also be an effective therapy for recalcitrant psoriatic arthritis and psoriasis, according to two new studies.

New antifungal treatment includes SEPA technology allowing more deliveryof medication through nail

When infection complicates treatment, dual drug treatment creates synergy

Although cases can vary by court, causal connection key to a plaintiff'scomplaint

Munich - Newer oral antifungals have efficacy similar to griseofulvin in tinea capitis, possibly with a shorter duration of therapy. But for now, the old and familiar standby should remain the treatment of choice, according to Peter Mayser, M.D., senior physician, Justus Liebig University, Giessen, Germany.

Munich - Much of the consideration of atopic dermatitis has been driven by the allergy model where an outside irritant contributes to the condition. Given that comparison, one might expect to see similar genes responsible for both conditions.

San Francisco - Both tumor necrosis factor (TNF) blockers etanercept and infliximab continue to play an emerging role in the treatment of psoriatic arthritis (PsA), according to two new studies presented at the American College of Rheumatology annual meeting here.

Munich - Dermatologists can objectively assess a patient's response to botulinum toxin-A treatment by using a digital camera and appropriate software, according to research recently published by Mark Heckmann, M.D.

Dallas - Knowing the different types of wound dressings available and their indications is important, but being able to assess wounds and determine whether the healing is proceeding well is an even more critical skill, Gregg M. Menaker, M.D., said at the annual joint meeting of the American Society of Dermatologic Surgery/American College of Mohs Micrographic Surgery and Oncology.

You stayed up late and now your skin is lackluster and your eyes aresporting dark shadows.

Office dispensing in dermatology practices has longbeen a controversial issue, yet physicians are finding that the trend hasgrown tremendously

Many of us began our computer experience when we learned word processing.As our computer skills improved, we added additional applications and atsome point connected to the Internet with a dial-up modem.

The destruction of benign, malignant, and premalignant lesions has beenand continues to be the main income stream

List of filler choices growing quickly; learn what is available anddevelop expertise with a few

A bexarotene management protocol has been developed at MD Anderson CancerCenter with the goal of maintaining treatment and optimizing efficacy andsafety

Response rates to bexarotene in patients with cutaneousT-cell lymphoma can be improved with the use of combination therapy

The number of available treatments for the symptoms ofscleroderma is increasing while the need for dermatologists to investigateorgan involvement is also on the rise

Dermatologists don't believe drug firm gifts jeopardize ethics

Physicians must be certain that patients provide video consent

Dermatologists responsible for raising bar in cosmetics, cosmeceuticals

DALLAS - The list of fillers for facial volume augmentation is long and growing, but in choosing among the many options, the most important thing for users to keep in mind, said Arnold W. Klein, M.D., is: "It's not what you use, but how you use it."

DALLAS - Guideline development can optimize management of dermatologic surgery patients with special needs, Clark C. Otley, M.D., said at the annual joint meeting of the American Society for Dermatologic Surgery and the American College of Mohs Micrographic Surgery and Cutaneous Oncology.

MUNICH - While primary cutaneous B-cell lymphomas must be clearly separated from non-Hodgkin's B-cell lymphomas with secondary cutaneous involvement and from cutaneous B-cell pseudolymphomas, "from the truly clinical and prognostic point of view, low-grade lymphomas are one disease," according to Nicola Pimpinelli, M.D., at the annual meeting of the European Academy of Dermatology and Venereology.

MUNICH - Dermatologists now have a clinical case that supports the loss of heterozygosity theory for rare Type 2 form of segmental types of autosomal dominant (AD) skin disorders, Peter Itin, M.D., said at the annual meeting of the European Academy of Dermatology and Venereology.

The Alliance of Medical Societies strongly endorsed legislation to stem a fee reduction of 5.4 percent included in the 2002 schedule released in November by the Centers for Medicare and Medicaid Services.

NUTLEY, N.J. - An FDA-approved program is offering a "smart" way to prevent pregnancies during isotretinoin (Accutane) use.

DALLAS - Knowing the different types of wound dressings available and their indications is important, but being able to assess wounds and determine whether the healing is proceeding well is an even more critical skill, Gregg M. Menaker, M.D., said at the annual joint meeting of the American Society of Dermatologic Surgery/American College of Mohs Micrographic Surgery and Oncology.

Ciprofloxacin (Cipro), the medicine of choice for treatingcutaneous anthrax as well as other forms of the disease, can cause adversedrug reactions in both the central nervous system and the peripheral nervoussystem, according to studies in The Journal of Pharmacotherapy

No amount of balm soothes my sore, chapped lips. Any ideas?

Can certain foods make me more likely to break out?